Market News & Trends
Quartzy & Lab Launch Partner to Make Critical Resources Available for New Labs
Quartzy recently announced its preferred partnership with Lab Launch Inc. to provide their labs with its time-saving software and comprehensive Quartzy Catalog. “We’re excited to be…
ReForm Biologics & KBI Biopharma Announce Strategic Partnership
ReForm Biologics and KBI BioPharma, Inc recently announced a strategic partnership to make improved biopharmaceutical formulations. Through this collaboration, KBI and ReForm will help customers…
XBiotech In-licenses Anti-NY-ESO-1 Antibody Targeting Advanced Cancer
XBiotech USA, Inc. recently announced it has obtained an exclusive, worldwide license from CT Atlantic AG (CTA), a Swiss biotechnology company. Under the terms of…
Stem Cell Technology Will Provide Revolutionary Treatments for Diseases
As stem cell technology has the ability to regenerate complex tissue of all types, it offers scope for revolutionary treatments for diseases that currently have…
TARA Scientific Co-Founders Grow Adult-Like Human Heart Tissue in Just 4 Weeks
TARA Biosystems Inc., a company offering physiologically relevant "heart-on-a-chip" tissue models for drug discovery and development applications, recently announced the publication of a landmark cardiac tissue…
Ferring Acquires Innovative Biotechnology Company and Microbiome Pioneer Rebiotix Inc.
Ferring Pharmaceuticals* and Rebiotix Inc. recently announced that they have agreed to the acquisition of Rebiotix by Ferring. This acquisition brings together two innovative healthcare…
Boehringer Ingelheim & OSE Immunotherapeutics Announce Global Immuno-Oncology Partnership
Boehringer Ingelheim and OSE Immunotherapeutics recently announced a collaboration and exclusive worldwide collaboration and license agreement to jointly develop OSE-172, a SIRP-alpha antagonist targeting myeloid…
MedPharm Receives Growth Equity Investment From Ampersand Capital Partners
MedPharm Ltd., a leading provider of contract topical and transdermal product design and formulation development services, recently announced a multi-million dollar investment by Ampersand Capital…
Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement With Lonza Bioscience Solutions
Organovo Holdings, Inc. recently announced its wholly owned subsidiary, Samsara Sciences, Inc., a provider of highly specialized human liver cells, entered a non-exclusive global supply…
Nuvaira Announces First Patient Treated in RELIEF-1 Study Evaluating New Approach for Asthma Treatment
Nuvaira recently announced treatment of the first patient in the RELIEF-1 Clinical Study in Europe. The RELIEF-1 trial (NCT02872298) is a prospective, multi-center, single-arm (non-randomized)…
SetPoint Medical Announces Trial to Evaluate First Bioelectronic Device
SetPoint Medical recently announced it has launched a pilot trial for patients with drug refractory rheumatoid arthritis (RA) in the US. The multi-center study, A…
Catalyst Biosciences Receives Two Milestone Payments
Catalyst Biosciences, Inc. recently announced it has received $1.5 million in milestone payments following the completion of two triggering events for its neuronal nicotinic receptor…
Krystal Submits IND Application for Topical Gene Therapy Candidate
Krystal Biotech Inc. recently announced the submission of an Investigational New Drug (IND) application with the US FDA to initiate a Phase 1/2, first in-human…
BioStem Technologies Announces Letter of Intent With CCM Pharma Solutions
BioStem Technologies, Inc. recently announced it has signed a Letter of Intent with CCM Pharma Solutions. CCM has identified several drugs in the cardiovascular, metabolic…
RedShiftBio Announces Collaboration Trial Completion
RedShift BioAnalytics, Inc. (RedShiftBio), a provider of analytical instrumentation for the characterization of protein therapeutics, recently announced the completion of Phase II of the company’s…
Inovio Closes License & Collaboration Agreement With ApolloBio
Inovio Pharmaceuticals, Inc. recently announced it has closed an agreement providing ApolloBio Corp. with the exclusive right to develop, manufacture, and commercialize VGX-3100, Inovio’s DNA…
Elligo Health Research Raises $16 Million to Improve Access to Clinical Trials
Elligo Health Research, which improves clinical trial access by engaging the 97% of physicians currently not offering clinical research to their patients, recently announced $16…
Cesca Therapeutics Expands CAR-TXpress Intellectual Property Portfolio
Cesca Therapeutics Inc. recently announced its device subsidiary, ThermoGenesis Corp., has filed a patent with the US PTO for a method of further simplifying the…
Innovest Global Signs Letter of Intent to Acquire 20% of StemVax Therapeutics
Innovest Global Inc. recently announced it has signed a Letter of Intent to acquire a 20% stake in StemVax LLC. StemVax is a Translational Biotechnology…
US PTO Awards BioPharmX Patent Protection for Novel Tetracycline-Class Topical Drug Compositions
BioPharmX Corporation recently announced the US PTO has granted the first in what the company expects will be a new family of patents protecting its…
